stockrow
Saturday 7 November 2026
Export RCKT’s income statement to Excel — free account
Rocket Pharmaceuticals, Inc.
RCKT Healthcare Biotechnology
- EPS
- +275.8%
- Free cash flow
- +19.2%
- Total debt
- −0.25%
Quarter to June 2026, against a year earlier
2.39
0.05
−2.05%
Follow RCKT
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
18.23 | 4.19 | 13.60 | 16.81 | 14.94 | 17.69 | 9.29 | 7.80 | 9.30 | 6.38 |
Net Debt/EBITDA |
10.33 | 0.93 | 2.32 | 3.41 | 3.32 | 2.28 | 1.55 | 1.40 | 1.34 | 0.77 |
Debt/Assets |
37.76% | 0.00% | 16.49% | 12.36% | 9.97% | 3.85% | 3.49% | 3.42% | 3.67% | 5.86% |
Debt/Equity |
0.67 | 0.00 | 0.21 | 0.15 | 0.12 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.73 | 0.82 | 0.72 | 0.84 | 0.53 | 0.72 | 0.80 | 0.79 | 0.81 | 0.85 |
Capex/Depreciation |
(5.00) | (3.73) | (4.34) | (54.62) | (3.02) | (1.42) | (1.33) | (2.32) | (0.63) | (0.04) |
Interest Coverage |
(17.10) | (9,886.00) | (11.78) | (12.78) | (19.28) | (56.18) | (120.48) | (138.48) | (144.86) | (122.55) |
| (8.32%) | (82.92%) | (88.66%) | (30.83%) | (34.46%) | (35.29%) | (46.98%) | (50.01%) | (54.14%) | (60.27%) | |
| (6.23%) | (26.14%) | (54.90%) | (24.79%) | (29.02%) | (31.08%) | (42.31%) | (43.93%) | (47.30%) | (52.00%) | |
ROIC |
0.00% | 0.00% | (149.47%) | (96.76%) | (105.28%) | (122.79%) | (91.91%) | (116.96%) | (154.83%) | (134.54%) |
Return on Tangible Assets |
(6.19%) | (126.97%) | (38.07%) | (24.23%) | (29.48%) | (43.11%) | (62.69%) | (66.58%) | (69.13%) | (117.00%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.12 | 0.08 | 0.05 | 0.06 | 0.12 | 0.11 | 0.12 | 0.19 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.85) | (2.46) | (1.40) | (1.79) | (1.72) | (2.04) | (2.74) | (2.52) | (2.27) | (1.71) |
Cash per Share |
18.51 | 2.67 | 5.22 | 6.21 | 8.72 | 6.15 | 5.23 | 4.44 | 3.93 | 1.70 |
Shareholders Equity per Share |
10.71 | 2.28 | 4.93 | 6.27 | 9.09 | 7.19 | 7.19 | 5.86 | 4.89 | 2.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.71 | 2.28 | 4.93 | 6.27 | 9.09 | 7.19 | 7.19 | 5.86 | 4.89 | 2.49 |
Free Cash Flow |
(5.84) | (16.72) | (55.22) | (87.93) | (95.25) | (128.78) | (186.50) | (211.35) | (215.59) | (190.45) |
Working Capital |
121.31 | 14.43 | 193.72 | 289.45 | 454.73 | 369.89 | 324.89 | 329.72 | 337.50 | 162.53 |
Capital Expenditures |
(0.33) | (0.76) | (1.43) | (23.27) | (20.61) | (7.62) | (8.36) | (16.44) | (5.86) | (0.44) |
Net Current Asset Value |
71.87 | 14.33 | 151.81 | 242.93 | 400.04 | 349.76 | 301.94 | 304.46 | 313.72 | 139.51 |
| Other line items | ||||||||||
Quick Ratio |
17.96 | 4.01 | 13.38 | 16.61 | 14.80 | 17.54 | 9.10 | 7.69 | 9.15 | 6.25 |
Depreciation/Fixed assets |
0.06 | 0.21 | 0.16 | 0.01 | 0.36 | 0.24 | 0.22 | 0.18 | 0.25 | 0.40 |
Cash ROIC |
(2.35%) | (49.68%) | (12.52%) | (13.38%) | (9.11%) | (14.93%) | (21.55%) | (23.88%) | (25.22%) | (39.23%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.81) | (2.35) | (1.37) | (1.32) | (1.35) | (1.92) | (2.61) | (2.32) | (2.21) | (1.71) |
Capex per Share |
(0.05) | (0.11) | (0.04) | (0.47) | (0.37) | (0.12) | (0.12) | (0.20) | (0.06) | 0.00 |
Average Payables |
1.61 | 3.06 | 9.95 | 16.36 | 21.41 | 22.54 | 28.14 | 41.22 | 41.81 | 32.56 |
Average Assets |
121.48 | 74.90 | 135.73 | 311.72 | 481.47 | 543.92 | 524.41 | 559.07 | 547.02 | 429.07 |
Average Common Equity |
90.99 | 23.61 | 84.05 | 250.67 | 405.41 | 479.12 | 472.21 | 491.13 | 477.90 | 370.23 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates